HIV Vaccine Trial's Pivotal Leap Toward Making Super Antibodies'

'At the most general level, the trial results show that one can design vaccines that induce antibodies with pre-specified genetic features, and this may herald a new era of precision vaccines.'

Related Keywords

United States ,American ,Timothy Schacker ,Scripps Research Institute ,Scripps Research ,American Association For The Advancement Of Science ,University Of Minnesota ,Cnn ,American Association ,Induces Rare Antibody Precursors ,Hiv Infection ,Shiv ,Hiv Vaccine ,Vaccine ,Influenza ,Flu ,Clinical Research ,Clinical Trials ,Linical Studies ,Genetics ,Hepatitis C ,Cv Hepatitisc Virus ,Allgrove Aaa Syndrome ,A Syndrome ,Riplea Syndrome ,Chalasia Addisonianism Alacrima Syndrome Aaas ,Lacrimia ,Blood ,Genomics ,Genomic Medicine ,Edicine Genomic ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med ,